Viewing Study NCT00335868


Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2025-12-28 @ 4:18 AM
Study NCT ID: NCT00335868
Status: UNKNOWN
Last Update Posted: 2013-12-18
First Post: 2006-06-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-03
Start Date Type: None
Primary Completion Date: 2009-12
Primary Completion Date Type: ESTIMATED
Completion Date: None
Completion Date Type: None
First Submit Date: 2006-06-08
First Submit QC Date: None
Study First Post Date: 2006-06-12
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-12-17
Last Update Post Date: 2013-12-18
Last Update Post Date Type: ESTIMATED